drugset / Trial / NCT01870648

Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan

NCT01870648

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to determine if the administration of a single dose of oral ondansetron (an anti-vomiting medication), compared to placebo, results in a reduction in intravenous (IV) rehydration therapy in children presenting for emergency department care with some dehydration, vomiting and diarrhea in Pakistan. SOME Dehydration is defined as 2 or more of the following signs and symptoms: * Restlessness, irritability * Sunken Eyes * Drinks eagerly, thirsty * Skin pinch goes back slowly

Timeline

Start
2014-05
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 2 mg Oral
Subject Ondansetron Other / unclassified 4 mg Oral